FILL/FINISH OUTSOURCED PHARMA CAPACITY UPDATE VIDEOS
Capacity Update April 2025: Fill/Finish
This presentation highlights how simplified execution with development, filling, and analytics under one roof ensures safe, efficacious products reach patients in need.
Bora Pharmaceuticals Capacity Update April 2025: Fill/Finish
Tara Lorenz, Sr. Director of Commercial Operations, speaks on our latest investments and expanded fill/finish capabilities and capacity for small molecules, biologics, and other sterile injectable products.
Simtra Biopharma Solutions Capacity Update April 2025: Fill/Finish
With expertise in process optimization, analytics, and regulatory strategy, we help partners de-risk development, accelerate time to market, and ensure manufacturability from the outset.
Mabion Capacity Update April 2025: Fill/Finish
Backed by years of dedication to customer-focused solutions, we’re proud to introduce our specialists to the global biopharma community and share insights that drive innovation forward.
Resilience Capacity Update April 2025: Fill/Finish
In this update, you will hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support manufacturing programs from clinical through commercial.
Curia Capacity Update April 2025: Fill/Finish
Discover how proven sterile fill-finish expertise, high-potency capabilities, and customizable cleanrooms can support your product from development to commercialization.
IDT Biologika Capacity Update April 2025: Fill/Finish
Watch as Senior Key Account Manager, Dr. Jürgen Lübbehusen highlights IDT Biologika´s overall fill-finish capabilities and capacities, with a focus on our ability to help meet your complex needs.
FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Fill/Finish
Executive Director of Technology and Business Development for Drug Product and Finished Goods, Henrik Herrmann, shares an update on the current and future state of FDB’s capabilities.
Argonaut Capacity Update April 2025: Fill/Finish
Advance your clinical and commercial programs with expert aseptic fill finish and formulation services across vials, cartridges, and syringes, all in state-of-the-art, EU Annex 1-compliant facilities.
Lonza Capacity Update January 2025: Fill/Finish
Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.
Lifecore Biomedical Capacity Update January 2025: Fill/Finish
Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics.
Jubilant HollisterStier Capacity Update January 2025: Fill/Finish
From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision.
FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish
Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project.
Alcami Capacity Update January 2025: Fill/Finish
Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes.
Capacity Update January 2025: Fill/Finish
This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges.
SMC Ltd. Capacity Update October 2024: Fill/Finish
Partner with us to access the critical services that drive your success — supporting everything from technical and development batches to Phase 1 clinical trials and product launch.
PCI Pharma Services Capacity Update October 2024: Fill/Finish
Jeff Clement, Executive Director of Technical Sales Drug Product Development and Manufacturing, outlines our global sterile fill-finish and lyophilization capabilities, investments, and expansions.
Novartis Contract Manufacturing Services Capacity Update October 2024: Fill/Finish
Let us support your high-quality medicines with integrated offerings in mammalian drug substances and drug products, including our fill and finish services for vials, syringes, cartridges, and auto-injectors.
Lifecore Biomedical Services Capacity Update October 2024: Fill/Finish
Our injectables CDMO expertise can support your molecule, with a team skilled in complex formulations, over 20 commercial products, a 40+ year regulatory history, and a new isolator filler capacity.
Jubilant HollisterStier Services Capacity Update October 2024: Fill/Finish
Our full-service model enables us to collaborate with partners on sterile injectable projects, delivering quality products for both early clinical stages and large-scale commercial supply.
INCOG BioPharma Services Capacity Update October 2024: Fill/Finish
Learn about our new facility expansions, enhanced filling capacity, and advanced packaging capabilities that are designed to support and elevate your drug development projects.
Curia Capacity Update: Inside The $200M Expansion In Albuquerque, NM
Enhance your injectable projects with our expertise and expanded capacity to meet the demand for vials, pre-filled syringes, and cartridges from pre-clinical development to commercial launch.
Argonaut Manufacturing Services Capacity Update October 2024: Fill/Finish
Discover high-quality GMP manufacturing capabilities, featuring a state-of-the-art isolator-based filling platform and extensive fill-finish capacity for vials, syringes, and cartridges.
Alcami Capacity Update October 2024: Fill/Finish
Alcami provides sterile drug product fill-finish services, including formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial production.
Ajinomoto Bio-Pharma Capacity Update October 2024: Fill/Finish
Explore our exceptional injectable manufacturing capabilities, featuring our high-speed, multi-purpose fill-finish line for vials, syringes, and cartridges at our San Diego facility.
Ajinomoto Bio-Pharma Services Capacity Update July 2024: Fill/Finish
Review our range of offerings including our high speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA.
FUJIFILM Diosynth Biotechnologies Capacity Update July 2024: Fill/Finish
Nadiyra Walker, Head of Drug Product and Finished Goods Manufacturing at FUJIFILM Diosynth Biotechnologies (FDB), presents an update on the state of FDB’s Drug Product and Finished Goods capabilities.
Singota Solutions Capacity Update July 2024: Fill/Finish
Review key services including drug formulation development, analytical testing, aseptic filling, pharmaceutical labeling and kitting, and supply chain management.
Mabion Capacity Update July 2024: Fill/Finish
Mabion, a biologics CDMO with end-to-end services focusing on recombinant proteins development and production, showcases new depyrogenation, fill finish vial capabilities, and CMC analytical proficiencies.
Simtra BioPharma Solutions Capacity Update July 2024: Fill/Finish
We currently have open capacity for development services as well as liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project.
Don't miss our next installment!
These conferences are ideal for professionals who have the authority to choose and manage CDMO relationships and need to secure capacity for their development or commercial programs.
How can we help?
Are you a supplier looking to present at our next event?